119 related articles for article (PubMed ID: 28160427)
1. Performance of Redox Active and Chelatable Iron Assays to Determine Labile Iron Release From Intravenous Iron Formulations.
Pai AB; Meyer DE; Bales BC; Cotero VE; Pai MP; Zheng N; Jiang W
Clin Transl Sci; 2017 May; 10(3):194-200. PubMed ID: 28160427
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo DFO-chelatable labile iron release profiles among commercially available intravenous iron nanoparticle formulations.
Pai AB; Pai MP; Meyer DE; Bales BC; Cotero VE; Zheng N; Jiang W
Regul Toxicol Pharmacol; 2018 Aug; 97():17-23. PubMed ID: 29857115
[TBL] [Abstract][Full Text] [Related]
3. Complexity of intravenous iron nanoparticle formulations: implications for bioequivalence evaluation.
Pai AB
Ann N Y Acad Sci; 2017 Nov; 1407(1):17-25. PubMed ID: 29027212
[TBL] [Abstract][Full Text] [Related]
4. In vitro study on the effects of iron sucrose, ferric gluconate and iron dextran on redox-active iron and oxidative stress.
Sturm B; Steinkellner H; Ternes N; Goldenberg H; Scheiber-Mojdehkar B
Arzneimittelforschung; 2010; 60(7):459-65. PubMed ID: 20712137
[TBL] [Abstract][Full Text] [Related]
5. Bioavailability and stability of intravenous iron sucrose originator versus generic iron sucrose AZAD.
Praschberger M; Cornelius C; Schitegg M; Goldenberg H; Scheiber-Mojdehkar B; Sturm B
Pharm Dev Technol; 2015 Mar; 20(2):176-82. PubMed ID: 24219061
[TBL] [Abstract][Full Text] [Related]
6. Comparative Evaluation of U.S. Brand and Generic Intravenous Sodium Ferric Gluconate Complex in Sucrose Injection: In Vitro Cellular Uptake.
Wu M; Sun D; Tyner K; Jiang W; Rouse R
Nanomaterials (Basel); 2017 Dec; 7(12):. PubMed ID: 29244729
[TBL] [Abstract][Full Text] [Related]
7. Effect of age and caloric restriction on bleomycin-chelatable and nonheme iron in different tissues of C57BL/6 mice.
Sohal RS; Wennberg-Kirch E; Jaiswal K; Kwong LK; Forster MJ
Free Radic Biol Med; 1999 Aug; 27(3-4):287-93. PubMed ID: 10468200
[TBL] [Abstract][Full Text] [Related]
8. Iron Oxide Nanoparticle Formulations for Supplementation.
Pai AB
Met Ions Life Sci; 2019 Jan; 19():. PubMed ID: 30855107
[TBL] [Abstract][Full Text] [Related]
9. CE characterization of potential toxic labile iron in colloidal parenteral iron formulations using off-capillary and on-capillary complexation with EDTA.
Jahn MR; Mrestani Y; Langguth P; Neubert RH
Electrophoresis; 2007 Jul; 28(14):2424-9. PubMed ID: 17577885
[TBL] [Abstract][Full Text] [Related]
10. Determination of the chelatable iron pool of isolated rat hepatocytes by digital fluorescence microscopy using the fluorescent probe, phen green SK.
Petrat F; Rauen U; de Groot H
Hepatology; 1999 Apr; 29(4):1171-9. PubMed ID: 10094962
[TBL] [Abstract][Full Text] [Related]
11. A comparative study of the physicochemical properties of iron isomaltoside 1000 (Monofer), a new intravenous iron preparation and its clinical implications.
Jahn MR; Andreasen HB; Fütterer S; Nawroth T; Schünemann V; Kolb U; Hofmeister W; Muñoz M; Bock K; Meldal M; Langguth P
Eur J Pharm Biopharm; 2011 Aug; 78(3):480-91. PubMed ID: 21439379
[TBL] [Abstract][Full Text] [Related]
12. Release of redox-active iron by muscle crush trauma: no liberation into the circulation.
Kerkweg U; Pamp K; Fieker J; Petrat F; Hider RC; de Groot H
Shock; 2010 May; 33(5):513-8. PubMed ID: 19823114
[TBL] [Abstract][Full Text] [Related]
13. Lysosomal redox-active iron is important for oxidative stress-induced DNA damage.
Kurz T; Leake A; von Zglinicki T; Brunk UT
Ann N Y Acad Sci; 2004 Jun; 1019():285-8. PubMed ID: 15247030
[TBL] [Abstract][Full Text] [Related]
14. A review of fluorescence methods for assessing labile iron in cells and biological fluids.
Espósito BP; Epsztejn S; Breuer W; Cabantchik ZI
Anal Biochem; 2002 May; 304(1):1-18. PubMed ID: 11969183
[TBL] [Abstract][Full Text] [Related]
15. Comparative Evaluation of U.S. Brand and Generic Intravenous Sodium Ferric Gluconate Complex in Sucrose Injection: Physicochemical Characterization.
Sun D; Rouse R; Patel V; Wu Y; Zheng J; Karmakar A; Patri AK; Chitranshi P; Keire D; Ma J; Jiang W
Nanomaterials (Basel); 2018 Jan; 8(1):. PubMed ID: 29303999
[TBL] [Abstract][Full Text] [Related]
16. Chelatable iron and copper can be released from extracorporeally circulated blood during cardiopulmonary bypass.
Moat NE; Evans TE; Quinlan GJ; Gutteridge JM
FEBS Lett; 1993 Aug; 328(1-2):103-6. PubMed ID: 7688319
[TBL] [Abstract][Full Text] [Related]
17. Determination of the chelatable iron pool of single intact cells by laser scanning microscopy.
Petrat F; de Groot H; Rauen U
Arch Biochem Biophys; 2000 Apr; 376(1):74-81. PubMed ID: 10729192
[TBL] [Abstract][Full Text] [Related]
18. Comparison of bleomycin-detectable iron and labile plasma iron assays.
Itkonen O; Vaahtera L; Parkkinen J
Clin Chem; 2013 Aug; 59(8):1271-3. PubMed ID: 23669528
[No Abstract] [Full Text] [Related]
19. LPI-labile plasma iron in iron overload.
Cabantchik ZI; Breuer W; Zanninelli G; Cianciulli P
Best Pract Res Clin Haematol; 2005 Jun; 18(2):277-87. PubMed ID: 15737890
[TBL] [Abstract][Full Text] [Related]
20. Quercetin as a shuttle for labile iron.
Baccan MM; Chiarelli-Neto O; Pereira RM; Espósito BP
J Inorg Biochem; 2012 Feb; 107(1):34-9. PubMed ID: 22172500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
